SB 2276 Hawaii Senate · 2020 Regular Session

RELATING TO PRESCRIPTION DRUGS.

Summary

Requires drug manufacturers to notify the insurance commissioner, prescription drug benefit plans, and pharmacy benefit managers if a proposed increase in the wholesale price of certain drugs would result in a per cent or more price increase over a twoyear period. Requires the drug manufacturer to identify and report to the insurance commissioner information on certain drugs whose wholesale acquisition cost increases by a certain amount during a specified time frame. Requires the insurance commissioner to post price information on the Department of Commerce and Consumer Affair's website. Imposes fines. Effective 1/1/2050. (SD1)

Bill status passed 3 of 5 stages cleared

Introduction

Jan 2020

Committee Review

Mar 2020

Senate Passage

Mar 2020

House Passage

Governor

Introduced Jan 17, 2020 Last action Mar 9, 2020

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 9, 2020

Committee

Referred to HLT, CPC, referral sheet 36

lower

Mar 3, 2020

Introduced

Received from Senate (Sen. Com. No. 183) in amended form (SD 1).

lower

Mar 3, 2020

Upper · Passed

Report adopted; Passed Third Reading. Ayes, 25; Aye(s) with reservations: none . Noes, 0 (none). Excused, 0 (none). Transmitted to House.

upper

Feb 25, 2020

Upper · Passed

The committee(s) on JDC recommend(s) that the measure be PASSED, UNAMENDED. The votes in JDC were as follows: 3 Aye(s): Senator(s) K. Rhoads, J.Keohokalole, Kim; Aye(s) with reservations: none ; 0 No(es): none; and 2 Excused: Senator(s) Gabbard, Fevella.

upper

Feb 21, 2020

Upper · Passed

The committee(s) on JDC will hold a public decision making on 02-25-20 12:30PM in conference room 016.

upper

Feb 14, 2020

Committee

Report adopted; Passed Second Reading, as amended (SD 1) and referred to JDC.

upper

Feb 14, 2020

Committee

Reported from CPH (Stand. Com. Rep. No. 2744) with recommendation of passage on Second Reading, as amended (SD 1) and referral to JDC.

upper

Feb 12, 2020

Upper · Passed

The committee(s) on CPH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPH were as follows: 5 Aye(s): Senator(s) Baker, S. Chang, Nishihara, L. Thielen, Wakai; Aye(s) with reservations: none ; 0 No(es): none; and 2 Excused: Senator(s) Ruderman, Fevella.

upper

Feb 11, 2020

Upper · Passed

The committee(s) on CPH deferred the measure until 02-12-20 10:00AM in conference room 229.

upper

Feb 7, 2020

Upper · Passed

The committee(s) on CPH deferred the measure until 02-11-20 10:15AM in conference room 229.

upper

Jan 31, 2020

Upper · Passed

The committee(s) on CPH deferred the measure until 02-07-20 9:30AM in conference room 229.

upper

Jan 28, 2020

Upper · Passed

The committee(s) on CPH deferred the measure until 01-31-20 9:30AM in conference room 229.

upper

Jan 24, 2020

Upper · Passed

The committee(s) on CPH has scheduled a public hearing on 01-28-20 9:00AM in conference room 229.

upper

Jan 21, 2020

Committee

Referred to CPH, JDC.

upper

Jan 17, 2020

Introduced

Introduced.

upper

7 primary · 0 co-sponsors